These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7180189)

  • 1. [Intervals for clinico-serological observation of syphilis patients after the termination of treatment].
    Vasil'ev TV; Milich MV; Ovchinnikov NM; Anton'ev AA; Vinokurov IN
    Vestn Dermatol Venerol; 1982 Sep; (9):29-33. PubMed ID: 7180189
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serological resistance after the treatment of syphilis patients].
    Frishman MP
    Vestn Dermatol Venerol; 1984 Jul; (7):32-4. PubMed ID: 6475275
    [No Abstract]   [Full Text] [Related]  

  • 3. [Time period for clinicoserological follow-up of patients finishing treatment for syphilis].
    Mirakhmedov UM; Liuban BL; Khashimov BI; Shadlovskaia TI
    Vestn Dermatol Venerol; 1981; (10):59-62. PubMed ID: 7303873
    [No Abstract]   [Full Text] [Related]  

  • 4. [Physician's tactics in cases of persistent positive serological tests after the treatment of early forms of syphilis].
    Il'in II; Iarovinskiĭ BG; Galeeva AS
    Vestn Dermatol Venerol; 1984 Nov; (11):57-61. PubMed ID: 6528740
    [No Abstract]   [Full Text] [Related]  

  • 5. [Late results in treating syphilis patients by reserve methods].
    Vinokurov IN; Rakhmanova NV; Toporovskiĭ LM
    Vestn Dermatol Venerol; 1988; (6):70-3. PubMed ID: 3176684
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immediate and long-term results of intensive treatment of patients with contageous variants of syphilis].
    Vasil'ev TV; Vinokurov IN; Kotrovskaia LG; Toporovskiĭ LM
    Vestn Dermatol Venerol; 1982; (1):74-7. PubMed ID: 7072363
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sensitivity of serological reactions in the clinico-serological follow-up and discharge from dispensary observation].
    Kliuvaeva NM; Sazonova LV; Chistiakova AM; Kliuvaev VV; Eloian AG
    Vestn Dermatol Venerol; 1985 Jun; (6):71-4. PubMed ID: 4036313
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-immunologic characteristics of patients with seroresistant syphilis].
    Markin IIa; Lezvinskaia EM; Pataridze IF; Sochugov BM
    Vestn Dermatol Venerol; 1989; (5):52-5. PubMed ID: 2773583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of control serological tests of former primo-secondary syphilitic patients treated with arsenic, bismuth and mercury from 9 to 36 years ago].
    Bolgert M
    Bull Acad Natl Med; 1972 Jun; 156(18):568-77. PubMed ID: 4633742
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavior of reactivity in syphilis-serological test methods. A mathematic evaluation using the trend calculation].
    Luger A; Spendlingwimmer I; Zips A; Ogris E; Hawlicek F; Pühringer R
    Z Hautkr; 1974 Jun; 49(12):529-40. PubMed ID: 4848122
    [No Abstract]   [Full Text] [Related]  

  • 11. [Late results of the combined therapy of syphilis].
    Koliadenko VG; Terletskiĭ VB; Shupen'ko NM
    Vestn Dermatol Venerol; 1982 Sep; (9):71-4. PubMed ID: 7180199
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical significance of the exacerbation reaction in syphilis].
    Frishman MP; Dunaeva GA
    Vestn Dermatol Venerol; 1975 Dec; (12):36-41. PubMed ID: 1229669
    [No Abstract]   [Full Text] [Related]  

  • 13. Asymptomatic neurosyphilis after doxycycline therapy for early latent syphilis.
    Zenilman JM; Rand S; Barditch P; Rompalo AM
    Sex Transm Dis; 1993; 20(6):346-7. PubMed ID: 8108759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Seroresistant forms of syphilis].
    Ovchinnikov NM; Vasil'ev TV; Sazonova LV; Vinokurov IN; Korbut SE
    Vestn Dermatol Venerol; 1980 May; (5):68-72. PubMed ID: 7385965
    [No Abstract]   [Full Text] [Related]  

  • 15. Are post-treatment follow-up visits at 1 and 2 months necessary in patients treated for early syphilis?
    Day S; Gedela K
    Sex Transm Infect; 2009 Dec; 85(7):561-2. PubMed ID: 19933405
    [No Abstract]   [Full Text] [Related]  

  • 16. Audit of the use of benzathine penicillin, post-treatment syphilis serology and partner notification of patients with early infectious syphilis.
    Chauhan M; Serisha B; Sankar KN; Pattman RS; Schmid ML
    Int J STD AIDS; 2006 Mar; 17(3):200-2. PubMed ID: 16510011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Follow-up of Reverin-treated patients in manifest, primary, secondary, tertiary and latent seropositive lues. IV].
    Matanić V
    Hautarzt; 1966 Mar; 17(3):121-3. PubMed ID: 5987520
    [No Abstract]   [Full Text] [Related]  

  • 18. Seronegative secondary syphilis in 2 patients coinfected with human immunodeficiency virus.
    Kingston AA; Vujevich J; Shapiro M; Hivnor CM; Jukic DM; Junkins-Hopkins JM; Jih DM; Kostman JR; James WD
    Arch Dermatol; 2005 Apr; 141(4):431-3. PubMed ID: 15837859
    [No Abstract]   [Full Text] [Related]  

  • 19. [Overtreatment in cases with positive serological syphilis reactions].
    Gjessing C; Loe G
    Tidsskr Nor Laegeforen; 1967 Dec; 87(23):1981-2. PubMed ID: 5590469
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of failure in the treatment of early syphilis with erythromycin].
    Dratwiński Z
    Przegl Dermatol; 1971; 58(1):69-71. PubMed ID: 5554743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.